@article{52c9a0348279449d92cdaacda84b8a3b,
title = "Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid",
keywords = "Cost-Benefit Analysis, Doxycycline, Humans, Pemphigoid, Bullous, Prednisolone, Quality-Adjusted Life Years",
author = "Tracey Sach",
year = "2018",
month = feb,
doi = "10.1111/bjd.16226",
language = "English",
volume = "178",
pages = "320--321",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley",
number = "2",
}